← Open Payments lookup

TOPE ADEYOMOLA: Open Payments

NPI 1285186965 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,500 in 150 payments from 13 companies in 2025. Trend: 2023 $882 · 2024 $1,520 · 2025 $2,500

Food & beverage: $2,500
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.35$387
Neurocrine BioSciences, Inc.13$347
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$323
Teva Pharmaceuticals USA, Inc.18$261
Otsuka America Pharmaceutical, Inc.12$223
Vanda Pharmaceuticals Inc.11$223
Alkermes, Inc.12$214
Janssen Pharmaceuticals, Inc9$203
ABBVIE INC.12$136
Axsome Therapeutics, Inc.3$56

Products named: COBENFY, INGREZZA, CAPLYTA, INVEGA SUSTENNA, FANAPT, REXULTI, ARISTADA, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.